Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Zhiwei Wu, Yaling Hu, Miao Xu, Zhen Chen, Wanqi Yang, Zhiwei Jiang, Minjie Li, Hui Jin, Guoliang Cui, Panpan Chen, Lei Wang, Guoqing Zhao, Yuzhu Ding, Yuliang Zhao, Weidong Yin
Topics & Concepts
MedicineTolerabilityPlaceboClinical endpointSeroconversionAdverse effectClinical trialImmunogenicityInternal medicineRandomized controlled trialImmunologyAntibodyAlternative medicinePathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesHeparin-Induced Thrombocytopenia and Thrombosis